Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Griffey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Structural Biology|June 19, 2001
Computational methods for RNA structure determinationF Major, R Griffey
Biochemical Pharmacology|June 21, 1991
Dissociation of decreases in renal cellular energetics and recovery of renal microsomal translation during chronic cyclosporine A administrationW C Buss, R Griffey
Magnetic Resonance in Medicine|September 1, 1987
Effect of the sampling rate on magnetic resonance imagingS Vinitski, R Griffey, M Fuka, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopyW L Sibbitt, L J Haseler, R R Griffey, et al.
The Biochemical Journal|December 1, 1995
Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexesS T Crooke, K M Lemonidis, L Neilson, et al.
Journal of Medicinal Chemistry|February 14, 1997
Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic propertiesJ A Monn, M J Valli, S M Massey, et al.
Journal of Medicinal Chemistry|March 26, 1999
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptorsJ A Monn, M J Valli, S M Massey, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Structural Biology|June 19, 2001
Computational methods for RNA structure determinationF Major, R Griffey
Biochemical Pharmacology|June 21, 1991
Dissociation of decreases in renal cellular energetics and recovery of renal microsomal translation during chronic cyclosporine A administrationW C Buss, R Griffey
Magnetic Resonance in Medicine|September 1, 1987
Effect of the sampling rate on magnetic resonance imagingS Vinitski, R Griffey, M Fuka, et al.
AJNR. American Journal of Neuroradiology|August 1, 1997
Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopyW L Sibbitt, L J Haseler, R R Griffey, et al.
The Biochemical Journal|December 1, 1995
Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexesS T Crooke, K M Lemonidis, L Neilson, et al.
Journal of Medicinal Chemistry|February 14, 1997
Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic propertiesJ A Monn, M J Valli, S M Massey, et al.
Journal of Medicinal Chemistry|March 26, 1999
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptorsJ A Monn, M J Valli, S M Massey, et al.
Pageof 1